Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy
Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )
6 Jun 2016

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA
Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016

First results of a prospective bendamustine/rituximab trial in patients with MCL

Dr Mathias Rummel - University of Giessen, Giessen, Germany
First results of a prospective bendamustine/rituximab trial in patients with MCL ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
6 Jun 2016

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016

Testing the safety and efficacy of the PD-L1 antibody durvalumab

Dr Christophe Massard - Institut Gustave Roussy, Paris, France
Testing the safety and efficacy of the PD-L1 antibody durvalumab ( Dr Christophe Massard - Institut Gustave Roussy, Paris, France )
6 Jun 2016

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma

Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy
Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )
6 Jun 2016

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Prof Charles Ryan and Prof Nick James
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )
6 Jun 2016

Advanced RET-rearranged NSCLC

Dr Takashi Seto and Dr Kiyotaka Yoh
Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )
6 Jun 2016

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA
Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )
6 Jun 2016

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK
Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )
6 Jun 2016

Radiotherapy modalities for locally advanced non-small cell lung cancer

Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA
Radiotherapy modalities for locally advanced non-small cell lung cancer ( Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation